ArticlemBio2025
Dynamic interactions of retroviral Gag condensates with nascent viral RNA at transcriptional burst sites: implications for genomic RNA packaging.
Article in mBio, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Update of
Authors and funding
2 authors.
Funding
Abstract
Retroviruses cause significant diseases in humans and animals, including acquired immunodeficiency syndrome and a wide range of malignancies. A crucial yet poorly understood step in the replication cycle is the recognition and selection of unspliced viral RNA (USvRNA) by the retroviral Gag protein, which binds to the psi (Ψ) packaging sequence in the 5' leader to package it as genomic RNA (gRNA) into nascent virions. It was previously thought that Gag initially bound gRNA in the cytoplasm. However, previous studies demonstrated that the Rous sarcoma virus (RSV) Gag protein traffics transiently through the nucleus, which is necessary for efficient gRNA packaging. These data formed a strong premise for the hypothesis that Gag selects nascent gRNA at transcription sites in the nucleus, the highest concentration of USvRNA molecules in the cell. To test this hypothesis, we used single-molecule labeling and imaging techniques to visualize fluorescently tagged, actively transcribing viral genomes and Gag proteins in living cells. Gag foci were observed in the nucleus, transiently co-localizing with USvRNA at transcriptional burst sites and forming viral ribonucleoprotein complexes. Furthermore, we found that RSV Gag interacts with Med26 and CTCF in the nucleus, suggesting a possible role for these factors in trafficking Gag to transcription sites. These results support a novel paradigm for retroviral assembly in which Gag traffics to transcriptional burst sites and interacts with nascent USvRNA through a dynamic kissing interaction to capture gRNA for incorporation into virions.IMPORTANCERetroviruses depend on the host cell transcription machinery to synthesize unspliced viral RNA (USvRNA), which serves as the genome selected by Gag for packaging. We previously reported that Rous sarcoma virus (RSV) Gag undergoes transient nucleocytoplasmic trafficking, which is needed for optimal genome packaging and co-localizes with USvRNA in the nucleus. Here, using live cell imaging, we found that the association of Gag with USvRNA at the transcriptional burst site is transient and dynamic. Both Gag and the RSV transcriptional burst are located near the periphery of the nucleus, which may facilitate viral RNA export. Our data also suggest that host transcription-associated factors may play a role in trafficking Gag to transcription sites.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.